Plus   Neg

Stock Alert: Medley Management Jumps 27% After Disclosing Insider Stakes

Shares of Medley Management Inc. (MDLY), an alternative asset management firm, are surging almost 27 percent or $2.51 in Thursday's morning trade at $11.81.

In a regulatory filing Wednesday, Medley Management disclosed significant insider transactions and changes in beneficial ownership of securities. As of January 19, 2021, the company's Co-CEO and Chief Investment Officer Brook Taube owns 32.8 percent of the company's shares, while Co-CEO and Co-Chairman Seth Taube owns a 16.4 percent stake.

Medley Management has traded in a range of $2.80 to $30.60 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Editors Pick
Chico's FAS Inc. (CHS) Tuesday reported a wider year-over-year net loss for the fourth quarter. Meanwhile, Kohl's Corp.'s (KSS) fourth-quarter net income grew 29 percent from the previous year. But Abercrombie & Fitch Co.'s (ANF) fourth-quarter net income decreased 1 percent from the prior year. The U.S. Food and Drug Administration has approved the marketing of a new robotically-assisted surgical device (RASD) that can facilitate transvaginal hysterectomy in certain patients using minimally-invasive surgical instruments. The Hominis Surgical System of Memic Innovative Surgery Ltd., the U.S. subsidiary of Israeli biotechnology company memic Ltd., has been granted marketing authorization. Canadian cannabis company Canopy Growth Corp. (CGC, WEED.TO) announced Tuesday the launch of its Cannabidiol (CBD) beverage brand Quatreau in the high-potential U.S. market. Quatreau will be sold on Canopy's one-stop U.S. e-commerce destination, www.shopcanopy.com. Quatreau is a premium ready-to-drink...
Follow RTT